MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Donati, R. J.
Right arrow Articles by Rasenick, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Donati, R. J.
Right arrow Articles by Rasenick, M. M.

Vol. 59, Issue 6, 1426-1432, June 2001

Chronic Treatment of C6 Glioma Cells with Antidepressant Drugs Results in a Redistribution of Gsalpha

Robert J. Donati, Chandrashekhar Thukral, and Mark M. Rasenick

Departments of Physiology and Biophysics (R.J.D., C.T., M.M.R.) and Psychiatry (M.M.R.), University of Illinois at Chicago, College of Medicine, Chicago, Illinois

Previous studies have demonstrated that chronic treatment of C6 glioma cells with the antidepressants desipramine and fluoxetine increases the Triton X-100 solubility of the G protein Gsalpha (Toki et al., 1999). The antidepressants also caused a 50% decrease in the amount of Gsalpha localized to caveolae-enriched membrane domains. In this study, laser scanning confocal microscopy reveals that Gsalpha is localized to the plasma membrane as well as the cytosol in both treated and control cells. However, striking differences are seen in the distribution of Gsalpha in the long cellular processes after chronic treatment with these antidepressant drugs. Control cells display Gsalpha along the entire process with an especially high concentration of that G protein at the distal ends. Desipramine- or fluoxetine-treated cells show a more centralized clustering of Gsalpha in the Golgi region of the cell and a drastic reduction of Gsalpha in the cellular processes. There is no change in the distribution of Goalpha after desipramine treatment and the antipsychotic drug chlorpromazine does not alter Gsalpha . These results suggest that antidepressant-induced changes in the association of Gsalpha with the plasma membrane may translate into altered cellular localization of this signal transducing protein. Thus, modification of the coupling between Gs-coupled receptors and adenylyl cyclase may underlie both antidepressant therapy and depressive illnesses. This report also suggests that modification of the membrane domain occupied by Gsalpha might represent a mechanism for chronic antidepressant effects.

Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J Biomol ScreenHome page
D.A. Ross, S. Lee, V. Reiser, J. Xue, K. Alves, S. Vaidya, A. Kreamer, R. Mull, E. Hudak, T. Hare, et al.
Multiplexed Assays by High-Content Imaging for Assessment of GPCR Activity
J Biomol Screen, July 1, 2008; 13(6): 449 - 455.
[Abstract] [PDF]

Home page
 J. Neurosci.Home page
R. J. Donati, Y. Dwivedi, R. C. Roberts, R. R. Conley, G. N. Pandey, and M. M. Rasenick
Postmortem Brain Tissue of Depressed Suicides Reveals Increased Gs{alpha} Localization in Lipid Raft Domains Where It Is Less Likely to Activate Adenylyl Cyclase
J. Neurosci., March 19, 2008; 28(12): 3042 - 3050.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
P. B. Sehgal and S. Mukhopadhyay
Pulmonary arterial hypertension: a disease of tethers, SNAREs and SNAPs?
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H77 - H85.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. B. Sehgal, S. Mukhopadhyay, F. Xu, K. Patel, and M. Shah
Dysfunction of Golgi tethers, SNAREs, and SNAPs in monocrotaline-induced pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1526 - L1542.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
B. Eisensamer, M. Uhr, S. Meyr, G. Gimpl, T. Deiml, G. Rammes, J. J. Lambert, W. Zieglgansberger, F. Holsboer, and R. Rupprecht
Antidepressants and Antipsychotic Drugs Colocalize with 5-HT3 Receptors in Raft-Like Domains
J. Neurosci., November 2, 2005; 25(44): 10198 - 10206.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
J. A. Allen, J. Z. Yu, R. J. Donati, and M. M. Rasenick
{beta}-Adrenergic Receptor Stimulation Promotes G{alpha}s Internalization through Lipid Rafts: A Study in Living Cells
Mol. Pharmacol., May 1, 2005; 67(5): 1493 - 1504.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
S. Avissar, A. Matuzany-Ruban, K. Tzukert, and G. Schreiber
{beta}-Arrestin-1 Levels: Reduced in Leukocytes of Patients With Depression and Elevated by Antidepressants in Rat Brain
Am J Psychiatry, November 1, 2004; 161(11): 2066 - 2072.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
B. Razani, S. E. Woodman, and M. P. Lisanti
Caveolae: From Cell Biology to Animal Physiology
Pharmacol. Rev., September 1, 2002; 54(3): 431 - 467.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics